charles river laboratories
(CRL:New York Consolidated)
Robert J. Bertolini
Independent Director, Chairman of Strategic Planning & Capital Allocation Committee, Member of Executive Committee and Member of Audit Committee,Charles River Laboratories International, Inc.
|Age||Total Calculated Compensation||This person is connected to 63 board members in 6 different organizations across 9 different industries.|
See Board Relationships
Mr. Robert J. Bertolini, also known as Bob, served as the President and Chief Financial Officer of Bausch & Lomb Holdings Incorporated since February 25, 2013. Mr. Bertolini served as the President and Chief Financial Officer of Bausch & Lomb Incorporated, Bausch & Lomb Holdings Incorporated, a subsidiary of Bausch & Lomb Holdings Incorporated. He served as the Chief Financial Officer and Executive Vice President at Merck & Co. Inc. He has an extensive experience in ...
251 Ballardvale StreetPhone: 781-222-6000
Wilmington, Massachusetts 01887
Board Members Memberships*
Director, Chairman of Audit Committee and Member of Strategic Planning & Capital Allocation Committee
Independent Director, Chairman of Strategic Planning & Capital Allocation Committee, Member of Executive Committee and Member of Audit Committee
Director and Member of Finance & Audit Committee
Rutgers, The State University of New Jersey
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jacqueline M. Lemke||Chief Executive Officer, President and Director|
Bioanalytical Systems Inc.
|Josef H. von Rickenbach||Founder, Chairman and Chief Executive Officer|
PAREXEL International Corporation
|Ge Li Ph.D.||Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee|
WuXi PharmaTech (Cayman) Inc.
|Thomas H. Pike||Chief Executive Officer and Director|
Quintiles Transnational Holdings Inc.
|Miroslav Reljanovic M.D.||Founder, Owner, Chief Executive Officer and Director|
|38.0K GBP||Compensation as of Fiscal Year 2014.|